Proteoglycan-based diversification of disease outcome in head and neck cancer patients identifies NG2/CSPG4 and syndecan-2 as unique relapse and overall survival predicting factors

Por Farnedi, Anna, Rossi, Silvia, Bertani, Nicoletta, Gulli, Mariolina, Silini, Enrico Maria, Mucignat, Maria Teresa, Poli, Tito, Sesenna, Enrico, Lanfranco, Davide, Montebugnoli, Lucio, Leonardi, Elisa, Marchetti, Claudio, Cocchi, Renato, Ambrosini-Spaltro, Andrea, Foschini, Maria Pia, Perris, Roberto
Publicado no BMC Cancer (2015)

Prognostic modeling of oral cancer by gene profiles and clinicopathological co-variables

Por Mes, Steven W., te Beest, Dennis, Poli, Tito, Rossi, Silvia, Scheckenbach, Kathrin, van Wieringen, Wessel N., Brink, Arjen, Bertani, Nicoletta, Lanfranco, Davide, Silini, Enrico M., van Diest, Paul J., Bloemena, Elisabeth, Leemans, C. René, van de Wiel, Mark A., Brakenhoff, Ruud H.
Publicado no Oncotarget (2017)